Therapy News and Research

RSS

KMI announces strategic distribution agreement with Mobility to market stroke therapy devices

Kinetic Muscles Inc., a leading developer of stroke therapy technology, today announced a strategic distribution agreement with Mobility Research, also of Tempe, that will allow Mobility to market KMI’s products in specific international markets.

23 Mar 2010

Short of specialists and cancer care

Associate Professor Bogda Koczwara, from the Medical Oncology Group of Australia, conducted the survey which found just 19 per cent of all those diagnosed with cancer were receiving chemotherapy.

23 Mar 2010

Physical therapy exercise improves postnatal well-being and reduces risk for PND

A physical therapy exercise and health education program is effective in improving postnatal well-being and reducing the risk for postnatal depression, according to a randomized controlled trial published in the March issue of Physical Therapy, the scientific journal of the American Physical Therapy Association.

23 Mar 2010

Passage of comprehensive health care reform legislation: AMCP praises Congress

The Academy of Managed Care Pharmacy congratulates Congress for passing historic, comprehensive health care reform legislation. The Academy is pleased that the final product will reflect a commitment to making quality health care available to millions of currently uninsured Americans. AMCP has long advocated for reforms that ensure safe, high quality, accessible and affordable health care services for all Americans.

23 Mar 2010

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee voted 7-1 that a validated test to identify the T315I mutation should be reviewed by the FDA prior to approval of OMAPRO™ (omacetaxine mepesuccinate).

23 Mar 2010

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.

23 Mar 2010

athenahealth introduces new patient communication service

athenahealth, Inc., a leading provider of Internet-based business services to physician practices, today announced the launch of athenaCommunicator, a new patient communication service that is fully integrated with athenahealth’s established web-based physician practice management and electronic health record services.

23 Mar 2010

$Radiographs often inconclusive in detecting hip and pelvic fractures in emergency department$

Radiographs often inconclusive in detecting hip and pelvic fractures in emergency department

Radiographs are often inconclusive in the detection of hip and pelvic fractures in the emergency department, according to a study in the April issue of the American Journal of Roentgenology (www.ajronline.org).

23 Mar 2010

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center were awarded a five-year $7.5 million grant to tease apart - in the most comprehensive way ever devised -the role of a single protein receptor in breast cells in cancer development and treatment.

22 Mar 2010

Treatments for preventing hamstring injuries

A brand new systematic review into the research of hamstring injuries has revealed that not enough is known about the effectiveness of current prevention methods for one of the most common sports injuries.

22 Mar 2010

Treatment options available for GAD

A little worry is normal, but people who constantly worry about daily concerns, even when times are good, may have generalized anxiety disorder.

22 Mar 2010

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the pending commercial launch of 13 new SFDA approved products over the next few quarters.

22 Mar 2010

EHSI closes funding agreement with Celulas Genetica

Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.

22 Mar 2010

BEMA Granisetron development program: BDSI announces positive meeting with FDA

BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company’s potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI’s plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.

22 Mar 2010

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx, Inc., today announced that it has undertaken a Phase II clinical trial of CCX140, a novel, orally-available small molecule compound designed to specifically target the chemokine receptor known as CCR2.

22 Mar 2010

BSD Medical files 510(k) submission for premarket clearance of Phase II MTX-180

BSD Medical Corporation today announced that the Company has filed a 510(k) submission with the U.S. Food and Drug Administration for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System for ablation of soft tissue.

22 Mar 2010

Physiquality offers personalized health and fitness programs across the U.S.

Physiquality, a new national health and wellness network, now offers personalized health and fitness programs and products supervised by qualified physical and occupational therapists, across the United States.

22 Mar 2010

AngioDynamics welcomes book on “Irreversible Electroporation”

AngioDynamics today welcomed the publication of the book “Irreversible Electroporation,” published by Springer Berlin Heidelberg.

22 Mar 2010

ATS Medical receives Canadian approval for commercialization of Simulus Annuloplasty Product Line

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that Health Canada-Medical Device Bureau, Therapeutic Products Programme has approved commercialization of the ATS Simulus® Annuloplasty Product Line for valve repair.

22 Mar 2010

Own blood plasma injection may provide relief for tendinopathy, where traditional treatment fails

When tendon trouble -- such as tennis elbow or Achilles tendon pain -- doesn’t respond to traditional treatment, an injection of the patient’s own blood plasma into the tendon may provide relief.

22 Mar 2010

Therapy News and Research

KMI announces strategic distribution agreement with Mobility to market stroke therapy devices

Short of specialists and cancer care

Physical therapy exercise improves postnatal well-being and reduces risk for PND

Passage of comprehensive health care reform legislation: AMCP praises Congress

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

athenahealth introduces new patient communication service

Radiographs often inconclusive in detecting hip and pelvic fractures in emergency department

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Treatments for preventing hamstring injuries

Treatment options available for GAD

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

EHSI closes funding agreement with Celulas Genetica

BEMA Granisetron development program: BDSI announces positive meeting with FDA

ChemoCentryx undertakes Phase II clinical trial of CCX140

BSD Medical files 510(k) submission for premarket clearance of Phase II MTX-180

Physiquality offers personalized health and fitness programs across the U.S.

AngioDynamics welcomes book on “Irreversible Electroporation”

ATS Medical receives Canadian approval for commercialization of Simulus Annuloplasty Product Line

Own blood plasma injection may provide relief for tendinopathy, where traditional treatment fails

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News